PONATINIB HYDROCHLORIDE

PONATINIB HYDROCHLORIDE was reported 5237 times

PONATINIB HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PERIARTHRITIS CALCAREA 11 0.3235
1 AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME 18 0.3051
2 TUMOUR CELL MOBILISATION 3 0.3000
3 COSTAL CARTILAGE FRACTURE 8 0.2353
4 TYROSINE KINASE MUTATION 5 0.2000
5 GRANULICATELLA INFECTION 8 0.1905
6 PHILADELPHIA POSITIVE ACUTE LYMPHOCYTIC LEUKAEMIA 26 0.1595
7 HAEMATOPOIETIC STEM CELL MOBILISATION 9 0.1406
8 ADRENAL CYST 11 0.1000
9 BLAST CELL CRISIS 29 0.0873
10 CHRONIC MYELOID LEUKAEMIA RECURRENT 44 0.0804
11 CHRONIC MYELOID LEUKAEMIA TRANSFORMATION 34 0.0762
12 METAMYELOCYTE COUNT INCREASED 9 0.0604
13 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA 72 0.0583
14 CENTRAL NERVOUS SYSTEM LEUKAEMIA 22 0.0560
15 MISCARRIAGE OF PARTNER 3 0.0545
16 HEPATIC CALCIFICATION 9 0.0545
17 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 128 0.0496
18 ARTICULAR CALCIFICATION 11 0.0491
19 BONE MARROW LEUKAEMIC CELL INFILTRATION 4 0.0488
20 RADIATION FIBROSIS - LUNG 3 0.0484
21 ICHTHYOSIS 12 0.0476
22 ICHTHYOSIS ACQUIRED 3 0.0448
23 GRAFT VERSUS HOST DISEASE IN EYE 10 0.0433
24 ADRENOMEGALY 9 0.0433
25 MYELOCYTE COUNT INCREASED 8 0.0426
26 IMMATURE GRANULOCYTE COUNT INCREASED 11 0.0389
27 GALLBLADDER OEDEMA 11 0.0375
28 ACUTE LYMPHOCYTIC LEUKAEMIA REFRACTORY 5 0.0370
29 MESENTERIC ARTERIAL OCCLUSION 5 0.0355
30 CONGENITAL MEGACOLON 4 0.0351
31 CHRONIC MYELOID LEUKAEMIA 150 0.0325
32 VIRAL HAEMORRHAGIC CYSTITIS 23 0.0323
33 SUBCLAVIAN ARTERY STENOSIS 5 0.0321
34 LEUKAEMIC INFILTRATION 4 0.0286
35 ARTHRITIS FUNGAL 2 0.0278
36 CYTOGENETIC ANALYSIS ABNORMAL 28 0.0267
37 BASOPHILIA 2 0.0267
38 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 11 0.0263
39 CEREBRAL VASCULAR OCCLUSION 3 0.0261
40 ACUTE LYMPHOCYTIC LEUKAEMIA 73 0.0258
41 STEM CELL TRANSPLANT 60 0.0240
42 PHILADELPHIA CHROMOSOME POSITIVE 17 0.0233
43 MOYAMOYA DISEASE 5 0.0229
44 BLAST CELLS PRESENT 11 0.0229
45 BONE MARROW NECROSIS 5 0.0214
46 PERIPHERAL ARTERY STENOSIS 10 0.0209
47 CEREBROVASCULAR STENOSIS 3 0.0203
48 LEUKAEMIA RECURRENT 34 0.0201
49 BONE MARROW TRANSPLANT 37 0.0195
50 ADRENAL ADENOMA 11 0.0185
51 DEVICE RELATED BACTERAEMIA 5 0.0161
52 FACIAL WASTING 4 0.0149
53 RENIN INCREASED 4 0.0147
54 TRANSPLANT 33 0.0139
55 ANAL FISTULA INFECTION 2 0.0134
56 DIAPHRAGMATIC DISORDER 10 0.0131
57 CHLOROMA 5 0.0118
58 RENAL ARTERY STENOSIS 16 0.0116
59 CHEMOTHERAPY 41 0.0108
60 EHLERS-DANLOS SYNDROME 5 0.0108
61 CEREBELLAR ISCHAEMIA 2 0.0108
62 CAMPYLOBACTER GASTROENTERITIS 6 0.0101
63 CAROTID ARTERIOSCLEROSIS 10 0.0097
64 ADENOVIRAL HAEMORRHAGIC CYSTITIS 2 0.0096
65 TRANSPLANTATION COMPLICATION 4 0.0095
66 OSTEOCHONDROSIS 11 0.0095
67 NEPHROCALCINOSIS 11 0.0093
68 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 6 0.0091
69 PRINZMETAL ANGINA 9 0.0090
70 VASCULAR STENOSIS 3 0.0087
71 GRAFT VERSUS HOST DISEASE IN SKIN 19 0.0086
72 PROCALCITONIN INCREASED 10 0.0085
73 PRIMARY BILIARY CHOLANGITIS 4 0.0085
74 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 3 0.0082
75 GRAFT VERSUS HOST DISEASE 58 0.0081
76 HUMAN RHINOVIRUS TEST POSITIVE 3 0.0080
77 ACCELERATED HYPERTENSION 3 0.0079
78 CEREBELLAR STROKE 3 0.0077
79 MONOCYTE COUNT DECREASED 9 0.0074
80 GASTROINTESTINAL WALL THICKENING 11 0.0073
81 ATOPY 2 0.0072
82 LIPASE INCREASED 55 0.0072
83 VASCULAR STENT STENOSIS 3 0.0071
84 DEVICE RELATED THROMBOSIS 7 0.0071
85 PREGNANCY OF PARTNER 5 0.0071
86 GRAFT VERSUS HOST DISEASE IN LIVER 5 0.0070
87 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 28 0.0069
88 FEBRILE INFECTION 8 0.0068
89 HAEMORRHOID OPERATION 3 0.0067
90 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 3 0.0064
91 MICROANGIOPATHY 6 0.0064
92 PULMONARY VASCULAR DISORDER 3 0.0064
93 GRAFT VERSUS HOST DISEASE IN LUNG 3 0.0063
94 ANGIOCENTRIC LYMPHOMA 3 0.0061
95 COMPLICATIONS OF TRANSPLANT SURGERY 3 0.0059
96 DEMYELINATING POLYNEUROPATHY 6 0.0058
97 BLOOD CHLORIDE INCREASED 10 0.0058
98 BLAST CELL COUNT INCREASED 6 0.0057
99 NEOPLASM PROGRESSION 197 0.0057
100 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 12 0.0056
101 CYTOPENIA 69 0.0056
102 PANCREATIC ENZYMES INCREASED 8 0.0055
103 DISEASE COMPLICATION 25 0.0055
104 PLATELET TRANSFUSION 7 0.0054
105 LIFE SUPPORT 3 0.0053
106 CAPILLARY LEAK SYNDROME 11 0.0053
107 RED CELL DISTRIBUTION WIDTH INCREASED 22 0.0053
108 CORONARY ARTERY STENOSIS 26 0.0052
109 GENE MUTATION 10 0.0050
110 REMISSION NOT ACHIEVED 3 0.0048
111 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 24 0.0047
112 ANAL SPHINCTER ATONY 2 0.0047
113 PARAINFLUENZAE VIRUS INFECTION 7 0.0046
114 HAEMOCHROMATOSIS 4 0.0043
115 EPSTEIN-BARR VIRUS INFECTION 27 0.0043
116 PERIPHERAL ARTERY THROMBOSIS 6 0.0043
117 PERIPHERAL ARTERY OCCLUSION 6 0.0043
118 STAPHYLOCOCCAL SEPSIS 21 0.0042
119 PANCREATITIS CHRONIC 10 0.0042
120 MENINGITIS BACTERIAL 6 0.0042
121 CHYLOTHORAX 3 0.0042
122 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 21 0.0041
123 CEREBRAL ARTERY STENOSIS 2 0.0041
124 RETINAL VASCULAR OCCLUSION 3 0.0041
125 BLADDER MASS 2 0.0040
126 CENTRAL NERVOUS SYSTEM VASCULITIS 2 0.0039
127 HAEMANGIOMA 9 0.0039
128 ACQUIRED GENE MUTATION 5 0.0038
129 INTERMITTENT CLAUDICATION 6 0.0038
130 STREPTOCOCCAL BACTERAEMIA 4 0.0037
131 ARTERIAL DISORDER 7 0.0037
132 BLOOD COUNT ABNORMAL 55 0.0036
133 CSF PROTEIN INCREASED 3 0.0036
134 APLASIA 7 0.0036
135 PERIPHERAL MOTOR NEUROPATHY 5 0.0036
136 AMYLASE INCREASED 13 0.0035
137 ARTERIAL STENOSIS 3 0.0034
138 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 13 0.0034
139 HYPERLEUKOCYTOSIS 3 0.0034
140 HYPOVENTILATION 11 0.0034
141 VASCULAR OCCLUSION 7 0.0033
142 PLATELET COUNT ABNORMAL 20 0.0033
143 SECONDARY IMMUNODEFICIENCY 4 0.0033
144 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 20 0.0033
145 VENOOCCLUSIVE LIVER DISEASE 16 0.0032
146 ARTERITIS 2 0.0032
147 RADIOTHERAPY 6 0.0031
148 LACTOSE INTOLERANCE 8 0.0031
149 SPLENIC RUPTURE 5 0.0030
150 PACKED RED BLOOD CELL TRANSFUSION 4 0.0030
151 THYROIDITIS 9 0.0030
152 BRAIN STEM INFARCTION 3 0.0029
153 CAROTID ARTERY STENOSIS 10 0.0029
154 NON-CARDIOGENIC PULMONARY OEDEMA 3 0.0028
155 PARAPARESIS 5 0.0028
156 BRONCHIAL WALL THICKENING 2 0.0028
157 PULMONARY SEPSIS 4 0.0027
158 HAEMATOTOXICITY 26 0.0027
159 AORTIC VALVE SCLEROSIS 2 0.0027
160 B-CELL TYPE ACUTE LEUKAEMIA 2 0.0027
161 ARTERIOSCLEROSIS CORONARY ARTERY 18 0.0027
162 VITH NERVE PARALYSIS 3 0.0026
163 SKIN WRINKLING 7 0.0026
164 PNEUMONIA INFLUENZAL 3 0.0025
165 BENIGN PROSTATIC HYPERPLASIA 13 0.0025
166 PERICARDIAL EFFUSION 58 0.0025
167 VENTRICULAR HYPOKINESIA 8 0.0025
168 ACUTE LEUKAEMIA 4 0.0025
169 EYELID SKIN DRYNESS 3 0.0025
170 SPLENOMEGALY 29 0.0025
171 SPLEEN DISORDER 4 0.0024
172 ESCHERICHIA URINARY TRACT INFECTION 10 0.0024
173 PUPIL FIXED 4 0.0023
174 OBLITERATIVE BRONCHIOLITIS 3 0.0023
175 EXFOLIATIVE RASH 6 0.0023
176 ABDOMINAL SEPSIS 2 0.0023
177 CYTOMEGALOVIRUS TEST POSITIVE 4 0.0022
178 ANAEMIA OF CHRONIC DISEASE 2 0.0022
179 WHITE BLOOD CELL COUNT ABNORMAL 14 0.0022
180 CARDIAC DYSFUNCTION 8 0.0021
181 CYTOKINE RELEASE SYNDROME 43 0.0021
182 ESCHERICHIA BACTERAEMIA 5 0.0021
183 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 3 0.0021
184 SKIN TOXICITY 12 0.0021
185 CEREBRAL THROMBOSIS 6 0.0021
186 DRUG RESISTANCE 54 0.0021
187 ARNOLD-CHIARI MALFORMATION 2 0.0021
188 URINE FLOW DECREASED 5 0.0021
189 SERUM FERRITIN INCREASED 11 0.0021
190 ARTERIAL THROMBOSIS 4 0.0021
191 NEOPLASM RECURRENCE 7 0.0021
192 CYTOMEGALOVIRUS INFECTION 34 0.0020
193 PANCREATITIS 108 0.0020
194 ACUTE PSYCHOSIS 5 0.0020
195 PANCYTOPENIA 111 0.0020
196 RETINAL ARTERY OCCLUSION 5 0.0020
197 PERIPHERAL VASCULAR DISORDER 10 0.0019
198 MYELITIS 3 0.0019
199 ELECTROCARDIOGRAM T WAVE ABNORMAL 3 0.0019
200 ARTERIOSCLEROSIS 18 0.0019
201 NON-CARDIAC CHEST PAIN 6 0.0019
202 NEUROGENIC BLADDER 4 0.0019
203 ENTEROCOCCAL INFECTION 9 0.0019
204 HERPES SIMPLEX 12 0.0018
205 STAPHYLOCOCCAL BACTERAEMIA 8 0.0018
206 PROTHROMBIN TIME PROLONGED 11 0.0018
207 TYPE 1 DIABETES MELLITUS 11 0.0018
208 BONE MARROW FAILURE 37 0.0018
209 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 5 0.0018
210 INGUINAL HERNIA 11 0.0018
211 CARDIAC FAILURE ACUTE 12 0.0018
212 ISCHAEMIC STROKE 32 0.0018
213 ENDOTRACHEAL INTUBATION 5 0.0018
214 PNEUMONIA FUNGAL 7 0.0018
215 SPLENIC INFARCTION 3 0.0017
216 PERIPHERAL ISCHAEMIA 7 0.0017
217 LEG AMPUTATION 7 0.0017
218 DERMATITIS BULLOUS 12 0.0017
219 RED BLOOD CELL COUNT DECREASED 47 0.0016
220 POOR PERIPHERAL CIRCULATION 7 0.0016
221 WHITE BLOOD CELL COUNT INCREASED 63 0.0016
222 BRONCHIECTASIS 11 0.0016
223 TRANSFUSION 17 0.0016
224 TRANSAMINASES INCREASED 36 0.0016
225 DERMATITIS EXFOLIATIVE 8 0.0016
226 AORTIC VALVE REPLACEMENT 2 0.0016
227 CAROTID ARTERY DISEASE 2 0.0016
228 BLOOD URIC ACID INCREASED 9 0.0016
229 PLATELET COUNT DECREASED 166 0.0016
230 ABDOMINAL OPERATION 2 0.0015
231 BICYTOPENIA 3 0.0015
232 HEPATOTOXICITY 34 0.0015
233 TONGUE DISORDER 11 0.0015
234 CELL DEATH 3 0.0015
235 RENAL CYST 12 0.0015
236 CYSTITIS HAEMORRHAGIC 6 0.0015
237 BONE PAIN 87 0.0015
238 FEBRILE NEUTROPENIA 97 0.0015
239 NEUTROPENIC COLITIS 3 0.0014
240 PLEURITIC PAIN 4 0.0014
241 BLOOD CREATININE ABNORMAL 5 0.0014
242 DERMATITIS EXFOLIATIVE GENERALISED 5 0.0014
243 ANGIOPATHY 8 0.0014
244 FEBRILE BONE MARROW APLASIA 6 0.0014
245 FACIAL PARALYSIS 12 0.0014
246 CHRONIC GRAFT VERSUS HOST DISEASE 5 0.0014
247 TUMOUR LYSIS SYNDROME 12 0.0014
248 CEREBRAL ISCHAEMIA 7 0.0014
249 SEPTIC SHOCK 59 0.0014
250 APRAXIA 2 0.0013
251 AXILLARY PAIN 2 0.0013
252 HEPATOCELLULAR INJURY 19 0.0013
253 ACUTE CORONARY SYNDROME 11 0.0013
254 CENTRAL VENOUS CATHETERISATION 4 0.0013
255 LEUKOCYTOSIS 24 0.0013
256 BLOOD LACTATE DEHYDROGENASE INCREASED 21 0.0013
257 BONE MARROW DISORDER 4 0.0013
258 THROMBOCYTOPENIA 148 0.0013
259 THROMBOPHLEBITIS SUPERFICIAL 4 0.0013
260 HOSPICE CARE 13 0.0013
261 ISCHAEMIC CARDIOMYOPATHY 4 0.0013
262 LYMPHOCYTE COUNT DECREASED 23 0.0013
263 BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0013
264 PANCREATITIS ACUTE 29 0.0013
265 PLEURAL EFFUSION 78 0.0013
266 INVESTIGATION 4 0.0013
267 URINARY TRACT OBSTRUCTION 3 0.0013
268 URINARY HESITATION 3 0.0013
269 LACUNAR INFARCTION 3 0.0013
270 SKIN EXFOLIATION 104 0.0012
271 CARDIOVASCULAR INSUFFICIENCY 2 0.0012
272 ASPERGILLUS INFECTION 8 0.0012
273 ARTHRITIS BACTERIAL 5 0.0012
274 PANCREATIC DISORDER 6 0.0012
275 CORONARY ARTERY BYPASS 7 0.0012
276 HYPERURICAEMIA 5 0.0012
277 ENTEROCOLITIS 7 0.0012
278 BLOOD IMMUNOGLOBULIN G DECREASED 3 0.0012
279 HAEMATOCRIT DECREASED 24 0.0012
280 MULTIPLE ORGAN DYSFUNCTION SYNDROME 34 0.0012
281 CONGESTIVE CARDIOMYOPATHY 5 0.0012
282 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 9 0.0012
283 PERIPHERAL SENSORY NEUROPATHY 7 0.0012
284 SYSTEMIC CANDIDA 3 0.0012
285 FULL BLOOD COUNT DECREASED 24 0.0012
286 CEREBELLAR INFARCTION 2 0.0012
287 DYSLIPIDAEMIA 6 0.0012
288 DIABETIC COMPLICATION 3 0.0012
289 CANCER PAIN 3 0.0012
290 HEPATOSPLENOMEGALY 3 0.0012
291 VIITH NERVE PARALYSIS 4 0.0012
292 EJECTION FRACTION DECREASED 18 0.0012
293 MUCORMYCOSIS 3 0.0012
294 BLOOD CALCIUM INCREASED 10 0.0011
295 CARDIAC ABLATION 2 0.0011
296 HEPATOMEGALY 11 0.0011
297 DRY SKIN 148 0.0011
298 BLOOD PHOSPHORUS INCREASED 3 0.0011
299 CAROTID ARTERY OCCLUSION 4 0.0011
300 ULCERATIVE KERATITIS 3 0.0011
301 CHOLESTASIS 21 0.0011
302 ACUTE GRAFT VERSUS HOST DISEASE 5 0.0011
303 HAEMOGLOBIN ABNORMAL 7 0.0011
304 ANGINA UNSTABLE 7 0.0011
305 LEUKOENCEPHALOPATHY 4 0.0011
306 ACUTE PULMONARY OEDEMA 6 0.0011
307 CEREBRAL INFARCTION 26 0.0011
308 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 10 0.0010
309 RETINAL VEIN OCCLUSION 3 0.0010
310 TUMOUR MARKER INCREASED 5 0.0010
311 PARAPLEGIA 3 0.0010
312 ATELECTASIS 10 0.0010
313 BRONCHOPULMONARY ASPERGILLOSIS 8 0.0010
314 THROMBOTIC MICROANGIOPATHY 10 0.0010
315 HYPERTRIGLYCERIDAEMIA 6 0.0010
316 LIVER FUNCTION TEST INCREASED 22 0.0010
317 CORONARY ARTERY DISEASE 31 0.0010
318 VENOUS THROMBOSIS 4 0.0010
319 VITREOUS FLOATERS 10 0.0010
320 HISTIOCYTOSIS HAEMATOPHAGIC 3 0.0010
321 OESOPHAGITIS 11 0.0010
322 BLOOD CULTURE POSITIVE 3 0.0010
323 AZOTAEMIA 4 0.0010
324 SKIN PAPILLOMA 4 0.0010
325 MIXED LIVER INJURY 3 0.0010
326 CEREBROVASCULAR DISORDER 3 0.0010
327 FUNGAL SKIN INFECTION 4 0.0010
328 EMBOLISM VENOUS 3 0.0010
329 KLEBSIELLA INFECTION 5 0.0010
330 GALLBLADDER OPERATION 4 0.0010
331 KERATITIS 3 0.0010
332 NEUTROPENIC SEPSIS 7 0.0010
333 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 7 0.0010
334 MYOCARDIAL ISCHAEMIA 11 0.0010
335 LEUKAEMIA 9 0.0010
336 CARDIOMYOPATHY 14 0.0009
337 TESTICULAR PAIN 3 0.0009
338 CLOSTRIDIUM DIFFICILE COLITIS 10 0.0009
339 HEPATIC CYTOLYSIS 12 0.0009
340 LOSS OF THERAPEUTIC RESPONSE 3 0.0009
341 SUPRAVENTRICULAR TACHYCARDIA 9 0.0009
342 RASH PAPULAR 21 0.0009
343 ACUTE MYELOID LEUKAEMIA RECURRENT 2 0.0009
344 PORTAL VEIN THROMBOSIS 3 0.0009
345 BACTERAEMIA 11 0.0009
346 BLOOD BILIRUBIN INCREASED 25 0.0009
347 BLINDNESS UNILATERAL 13 0.0009
348 HYPERTENSION 195 0.0009
349 LYMPHOCYTE COUNT INCREASED 3 0.0009
350 POLYNEUROPATHY 11 0.0009
351 SEPSIS 102 0.0009
352 CEREBELLAR SYNDROME 2 0.0009
353 HYPERKERATOSIS 5 0.0009
354 LUNG INFILTRATION 8 0.0009
355 CYTOMEGALOVIRUS INFECTION REACTIVATION 4 0.0009
356 WHEELCHAIR USER 4 0.0009
357 NECROSIS 5 0.0009
358 PULMONARY ARTERIAL HYPERTENSION 13 0.0009
359 PNEUMOCYSTIS JIROVECII PNEUMONIA 9 0.0009
360 LEFT VENTRICULAR DYSFUNCTION 6 0.0009
361 LIVER FUNCTION TEST ABNORMAL 26 0.0009
362 HOSPITALISATION 137 0.0009
363 OSTEOMYELITIS 16 0.0009
364 MITRAL VALVE INCOMPETENCE 10 0.0009
365 CHOLECYSTITIS ACUTE 5 0.0009
366 ACUTE MYOCARDIAL INFARCTION 26 0.0009
367 CONSTIPATION 192 0.0009
368 DISEASE PROGRESSION 104 0.0009
369 EUPHORIC MOOD 9 0.0009
370 DEATH 756 0.0009
371 FUNCTIONAL GASTROINTESTINAL DISORDER 3 0.0009
372 NEUTROPENIA 118 0.0009
373 HEPATIC ENZYME INCREASED 59 0.0009
374 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 2 0.0009
375 EXTRASYSTOLES 6 0.0009
376 THROMBOPHLEBITIS 3 0.0009
377 ERYTHEMA NODOSUM 3 0.0009
378 DISSEMINATED INTRAVASCULAR COAGULATION 12 0.0009
379 FIBRIN D DIMER INCREASED 3 0.0008
380 CARDIAC TAMPONADE 4 0.0008
381 RESPIRATORY DISTRESS 23 0.0008
382 BONE LESION 3 0.0008
383 RASH VESICULAR 4 0.0008
384 RASH PUSTULAR 6 0.0008
385 THROMBOCYTOSIS 3 0.0008
386 PULMONARY MASS 12 0.0008
387 RETINOPATHY 3 0.0008
388 HEPATIC NECROSIS 3 0.0008
389 TOXIC SKIN ERUPTION 8 0.0008
390 IMMUNOSUPPRESSION 7 0.0008
391 BRAIN ABSCESS 2 0.0008
392 LIVER DISORDER 35 0.0008
393 TOE AMPUTATION 4 0.0008
394 CARDIOTOXICITY 7 0.0008
395 MYOSITIS 7 0.0008
396 PRODUCT TEMPERATURE EXCURSION ISSUE 4 0.0008
397 LYMPHOPENIA 11 0.0008
398 AORTIC ARTERIOSCLEROSIS 2 0.0008
399 OPTIC ISCHAEMIC NEUROPATHY 3 0.0008
400 RASH GENERALISED 20 0.0008
401 PULMONARY HYPERTENSION 16 0.0008
402 GAMMA-GLUTAMYLTRANSFERASE INCREASED 17 0.0008
403 ARTERIAL OCCLUSIVE DISEASE 6 0.0008
404 LYMPHADENOPATHY 27 0.0008
405 APHASIA 23 0.0008
406 HYPOGAMMAGLOBULINAEMIA 5 0.0008
407 SUDDEN DEATH 8 0.0008
408 RASH ERYTHEMATOUS 36 0.0008
409 BLOOD DISORDER 6 0.0007
410 ARTERIOSPASM CORONARY 3 0.0007
411 STENT PLACEMENT 6 0.0007
412 HEPATITIS 19 0.0007
413 C-REACTIVE PROTEIN INCREASED 27 0.0007
414 BLOOD SODIUM INCREASED 2 0.0007
415 TRANSIENT ISCHAEMIC ATTACK 25 0.0007
416 CHEST PAIN 137 0.0007
417 PYREXIA 255 0.0007
418 THERAPY NON-RESPONDER 33 0.0007
419 ABNORMAL FAECES 6 0.0007
420 NEPHROTIC SYNDROME 5 0.0007
421 CORONARY ARTERY OCCLUSION 10 0.0007
422 ATRIAL FIBRILLATION 71 0.0007
423 PERIPHERAL COLDNESS 10 0.0007
424 HEPATIC FUNCTION ABNORMAL 27 0.0007
425 SECOND PRIMARY MALIGNANCY 6 0.0007
426 ASCITES 21 0.0007
427 NEUTROPHIL COUNT DECREASED 29 0.0007
428 CARDIOVASCULAR DISORDER 18 0.0007
429 HEPATIC PAIN 3 0.0007
430 WHITE BLOOD CELL COUNT DECREASED 76 0.0007
431 PULMONARY OEDEMA 31 0.0007
432 ABDOMINAL PAIN 160 0.0007
433 MUCOSAL INFLAMMATION 18 0.0007
434 SUBARACHNOID HAEMORRHAGE 7 0.0007
435 CLOSTRIDIUM DIFFICILE INFECTION 15 0.0007
436 FLUID OVERLOAD 10 0.0007
437 GASTRITIS 18 0.0007
438 NIGHT SWEATS 22 0.0007
439 ORAL DISORDER 5 0.0007
440 ACUTE RESPIRATORY DISTRESS SYNDROME 12 0.0007
441 DRUG ERUPTION 12 0.0007
442 HYPERLIPIDAEMIA 8 0.0007
443 ATYPICAL PNEUMONIA 2 0.0007
444 IRON DEFICIENCY 3 0.0007
445 PAPILLOEDEMA 3 0.0007
446 GANGRENE 4 0.0007
447 HEPATIC FAILURE 20 0.0007
448 SKIN DISORDER 22 0.0007
449 DERMATITIS ACNEIFORM 4 0.0007
450 SKIN LESION 18 0.0007
451 BRAIN DEATH 2 0.0006
452 GENERALISED OEDEMA 8 0.0006
453 MUSCULOSKELETAL CHEST PAIN 10 0.0006
454 HEPATIC STEATOSIS 12 0.0006
455 PERFORMANCE STATUS DECREASED 3 0.0006
456 SKIN ABRASION 3 0.0006
457 HAEMOGLOBIN DECREASED 65 0.0006
458 PULSE ABSENT 3 0.0006
459 ANGINA PECTORIS 18 0.0006
460 GASTROINTESTINAL TOXICITY 3 0.0006
461 RASH 272 0.0006
462 OCULAR DISCOMFORT 7 0.0006
463 MYALGIA 106 0.0006
464 HAEMORRHOIDS 12 0.0006
465 ENCEPHALOPATHY 15 0.0006
466 MYELOSUPPRESSION 22 0.0006
467 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 5 0.0006
468 SARS-COV-2 TEST POSITIVE 8 0.0006
469 VENTRICULAR TACHYCARDIA 10 0.0006
470 ORGANISING PNEUMONIA 3 0.0006
471 DRUG LEVEL INCREASED 10 0.0006
472 VEIN DISORDER 3 0.0006
473 EYE HAEMORRHAGE 8 0.0006
474 SKIN MASS 4 0.0006
475 MENINGITIS 4 0.0006
476 HYPOXIA 21 0.0006
477 PERICARDITIS 10 0.0006
478 BK VIRUS INFECTION 2 0.0006
479 FACE OEDEMA 10 0.0006
480 ANAEMIA 112 0.0006
481 RASH MACULO-PAPULAR 13 0.0006
482 CACHEXIA 3 0.0006
483 SKIN HYPERPIGMENTATION 5 0.0006
484 HYPERBILIRUBINAEMIA 6 0.0006
485 SKIN NECROSIS 3 0.0006
486 NEUROPATHY PERIPHERAL 55 0.0006
487 ACUTE MYELOID LEUKAEMIA 9 0.0006
488 BLOOD PRESSURE INCREASED 86 0.0006
489 INTERNATIONAL NORMALISED RATIO INCREASED 16 0.0006
490 DRUG INTOLERANCE 54 0.0006
491 SUBDURAL HAEMATOMA 8 0.0006
492 GASTROINTESTINAL INFECTION 5 0.0006
493 INTERSTITIAL LUNG DISEASE 27 0.0006
494 CARDIOGENIC SHOCK 8 0.0006
495 GOUT 10 0.0006
496 DERMATITIS ALLERGIC 7 0.0006
497 HIP SURGERY 3 0.0006
498 MYELODYSPLASTIC SYNDROME 8 0.0006
499 FAECALOMA 3 0.0005
500 MAJOR DEPRESSION 4 0.0005
501 STAPHYLOCOCCAL INFECTION 18 0.0005
502 INTESTINAL ISCHAEMIA 3 0.0005
503 PNEUMONIA BACTERIAL 5 0.0005
504 MENTAL STATUS CHANGES 15 0.0005
505 FUNGAL INFECTION 18 0.0005
506 ARTHROPOD BITE 4 0.0005
507 HYPERTENSIVE CRISIS 6 0.0005
508 IMMUNODEFICIENCY 8 0.0005
509 MALNUTRITION 6 0.0005
510 CARDIAC FAILURE 43 0.0005
511 CARDIAC FAILURE CONGESTIVE 43 0.0005
512 BLOOD CALCIUM DECREASED 6 0.0005
513 CATHETER SITE INFECTION 2 0.0005
514 GENERALISED ERYTHEMA 3 0.0005
515 MALIGNANT NEOPLASM PROGRESSION 54 0.0005
516 HYPERTHERMIA 4 0.0005
517 BLOOD ALKALINE PHOSPHATASE INCREASED 13 0.0005
518 RALES 3 0.0005
519 MUSCULOSKELETAL PAIN 27 0.0005
520 VASCULITIS 6 0.0005
521 TORSADE DE POINTES 4 0.0005
522 DIVERTICULITIS 14 0.0005
523 SINUS HEADACHE 3 0.0005
524 CHOLECYSTITIS 6 0.0005
525 HYPOMAGNESAEMIA 7 0.0005
526 ATRIAL FLUTTER 4 0.0005
527 SQUAMOUS CELL CARCINOMA OF SKIN 3 0.0005
528 THERAPEUTIC RESPONSE DECREASED 30 0.0005
529 NOCTURIA 6 0.0005
530 LIVER INJURY 12 0.0005
531 CARDIOMEGALY 6 0.0005
532 HYPERAESTHESIA 4 0.0005
533 CEREBROVASCULAR ACCIDENT 82 0.0005
534 OEDEMA PERIPHERAL 59 0.0005
535 HEMIPLEGIA 4 0.0005
536 FOLLICULITIS 5 0.0005
537 TREATMENT NONCOMPLIANCE 26 0.0005
538 MUSCLE ATROPHY 6 0.0005
539 ASPARTATE AMINOTRANSFERASE INCREASED 25 0.0005
540 CARDIAC DISORDER 44 0.0005
541 ENTERITIS 3 0.0005
542 POOR QUALITY SLEEP 10 0.0005
543 CARDIAC FLUTTER 3 0.0005
544 DECREASED ACTIVITY 5 0.0005
545 DEEP VEIN THROMBOSIS 30 0.0005
546 PYELONEPHRITIS 4 0.0005
547 PLATELET COUNT INCREASED 6 0.0005
548 PULMONARY THROMBOSIS 5 0.0005
549 INFECTION 66 0.0005
550 DEVICE RELATED INFECTION 7 0.0005
551 BLOOD PRESSURE ABNORMAL 9 0.0005
552 NEPHROPATHY TOXIC 5 0.0004
553 COLITIS ISCHAEMIC 3 0.0004
554 ARRHYTHMIA 21 0.0004
555 EYE INFECTION 5 0.0004
556 ABDOMINAL PAIN UPPER 91 0.0004
557 BODY TEMPERATURE INCREASED 9 0.0004
558 OPTIC NEURITIS 4 0.0004
559 ALANINE AMINOTRANSFERASE INCREASED 27 0.0004
560 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
561 BUNDLE BRANCH BLOCK RIGHT 2 0.0004
562 PNEUMONIA 141 0.0004
563 GASTRIC HAEMORRHAGE 5 0.0004
564 HAIR GROWTH ABNORMAL 3 0.0004
565 HYPERTRANSAMINASAEMIA 3 0.0004
566 MYOCARDIAL INFARCTION 75 0.0004
567 RENAL FAILURE 57 0.0004
568 HEADACHE 268 0.0004
569 SKIN ULCER 11 0.0004
570 RESPIRATORY FAILURE 31 0.0004
571 RASH PRURITIC 23 0.0004
572 PULMONARY TOXICITY 3 0.0004
573 MUSCULAR WEAKNESS 48 0.0004
574 ATAXIA 5 0.0004
575 COAGULOPATHY 7 0.0004
576 URINARY RETENTION 14 0.0004
577 EYE INFLAMMATION 4 0.0004
578 ACUTE RESPIRATORY FAILURE 8 0.0004
579 TYPE 2 DIABETES MELLITUS 14 0.0004
580 ALTERED STATE OF CONSCIOUSNESS 9 0.0004
581 BRADYCARDIA 22 0.0004
582 HYPERCHOLESTEROLAEMIA 4 0.0004
583 PAIN IN EXTREMITY 122 0.0004
584 ERUCTATION 8 0.0004
585 SKIN DISCOLOURATION 19 0.0004
586 MOUTH HAEMORRHAGE 3 0.0004
587 HYPOPHOSPHATAEMIA 3 0.0004
588 ABDOMINAL TENDERNESS 2 0.0004
589 ILEUS 5 0.0004
590 LOCAL SWELLING 7 0.0004
591 HYPOTONIA 4 0.0004
592 BACK PAIN 93 0.0004
593 OFF LABEL USE 350 0.0004
594 THROMBOSIS 32 0.0004
595 ARTHRALGIA 164 0.0004
596 TROPONIN INCREASED 3 0.0004
597 HAEMODYNAMIC INSTABILITY 3 0.0004
598 TOOTH ABSCESS 4 0.0004
599 CHILLS 46 0.0004
600 SHOCK 9 0.0004
601 CEREBRAL HAEMORRHAGE 14 0.0004
602 RENAL DISORDER 18 0.0004
603 LUNG INFECTION 6 0.0004
604 THERAPY PARTIAL RESPONDER 6 0.0004
605 DECREASED APPETITE 89 0.0004
606 APLASTIC ANAEMIA 2 0.0004
607 DRY EYE 19 0.0004
608 IMMUNE SYSTEM DISORDER 5 0.0004
609 TOOTH INFECTION 5 0.0004
610 FURUNCLE 3 0.0004
611 FULL BLOOD COUNT ABNORMAL 4 0.0004
612 BLOOD ALBUMIN DECREASED 3 0.0004
613 RENAL PAIN 4 0.0004
614 CELLULITIS 19 0.0004
615 DYSSTASIA 11 0.0004
616 AGRANULOCYTOSIS 7 0.0004
617 NECK PAIN 21 0.0004
618 HYPOTHYROIDISM 12 0.0004
619 BACTERIAL INFECTION 7 0.0004
620 LABORATORY TEST ABNORMAL 11 0.0004
621 PHOTOPHOBIA 7 0.0004
622 MUSCLE TIGHTNESS 6 0.0004
623 BLOOD POTASSIUM INCREASED 6 0.0004
624 POST PROCEDURAL INFECTION 3 0.0004
625 UVEITIS 5 0.0004
626 DECUBITUS ULCER 3 0.0004
627 LUNG DISORDER 18 0.0004
628 NO ADVERSE EVENT 66 0.0004
629 ASTHENOPIA 2 0.0004
630 GASTROINTESTINAL PAIN 4 0.0004
631 EMBOLISM 3 0.0004
632 VIRAL INFECTION 12 0.0004
633 VENTRICULAR FIBRILLATION 4 0.0004
634 EOSINOPHIL COUNT INCREASED 3 0.0004
635 SKIN REACTION 5 0.0004
636 PAIN IN JAW 10 0.0004
637 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 9 0.0003
638 CARDIAC MURMUR 3 0.0003
639 DELIRIUM 12 0.0003
640 HYPERTHYROIDISM 5 0.0003
641 POST PROCEDURAL HAEMORRHAGE 4 0.0003
642 RASH MACULAR 12 0.0003
643 JOINT STIFFNESS 9 0.0003
644 ASTHENIA 129 0.0003
645 GROIN PAIN 3 0.0003
646 SPINAL OSTEOARTHRITIS 3 0.0003
647 COVID-19 PNEUMONIA 4 0.0003
648 CATARACT OPERATION 2 0.0003
649 CHOLELITHIASIS 11 0.0003
650 DERMATITIS 7 0.0003
651 FATIGUE 260 0.0003
652 ANAL INCONTINENCE 3 0.0003
653 BLOOD PRESSURE INADEQUATELY CONTROLLED 2 0.0003
654 LACRIMATION INCREASED 10 0.0003
655 PNEUMONITIS 9 0.0003
656 VISION BLURRED 45 0.0003
657 EPILEPSY 10 0.0003
658 CARDIAC ARREST 27 0.0003
659 UROSEPSIS 3 0.0003
660 SMALL INTESTINAL OBSTRUCTION 4 0.0003
661 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
662 HYPERCALCAEMIA 4 0.0003
663 ABASIA 8 0.0003
664 ERYTHEMA MULTIFORME 3 0.0003
665 NEPHROPATHY 3 0.0003
666 HAEMATURIA 11 0.0003
667 DRY MOUTH 26 0.0003
668 NERVOUS SYSTEM DISORDER 10 0.0003
669 FLANK PAIN 3 0.0003
670 TACHYCARDIA 28 0.0003
671 C-REACTIVE PROTEIN ABNORMAL 2 0.0003
672 ERECTILE DYSFUNCTION 8 0.0003
673 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0003
674 AUTOIMMUNE DISORDER 3 0.0003
675 VITAMIN D DEFICIENCY 3 0.0003
676 ACUTE KIDNEY INJURY 47 0.0003
677 DYSPHAGIA 29 0.0003
678 THERAPY CHANGE 3 0.0003
679 EYE DISORDER 10 0.0003
680 ORAL CANDIDIASIS 4 0.0003
681 HYPOKALAEMIA 14 0.0003
682 TREATMENT FAILURE 25 0.0003
683 GAIT INABILITY 10 0.0003
684 DYSURIA 11 0.0003
685 GASTROOESOPHAGEAL REFLUX DISEASE 24 0.0003
686 STOMATITIS 18 0.0003
687 EYELID PTOSIS 3 0.0003
688 HEMIPARESIS 5 0.0003
689 ANGIOEDEMA 13 0.0003
690 CHEST DISCOMFORT 30 0.0003
691 GINGIVAL BLEEDING 4 0.0003
692 INITIAL INSOMNIA 3 0.0003
693 DYSPNOEA EXERTIONAL 11 0.0003
694 INFLAMMATION 15 0.0003
695 NASAL CONGESTION 17 0.0003
696 VENTRICULAR EXTRASYSTOLES 3 0.0003
697 MUSCLE SPASMS 53 0.0003
698 PETECHIAE 3 0.0003
699 SPEECH DISORDER 15 0.0003
700 MASS 4 0.0003
701 NEUROTOXICITY 5 0.0003
702 HEART RATE DECREASED 10 0.0003
703 BLOOD TEST ABNORMAL 4 0.0003
704 SCRATCH 3 0.0003
705 HYPONATRAEMIA 16 0.0003
706 EYE PAIN 16 0.0003
707 SINUS TACHYCARDIA 4 0.0003
708 LETHARGY 16 0.0003
709 DEHYDRATION 37 0.0003
710 GENERAL PHYSICAL HEALTH DETERIORATION 32 0.0003
711 TOOTHACHE 5 0.0003
712 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
713 HYPERGLYCAEMIA 10 0.0003
714 GASTROENTERITIS 4 0.0003
715 ASPIRATION 3 0.0003
716 VISUAL ACUITY REDUCED 9 0.0003
717 NERVE INJURY 3 0.0003
718 WEIGHT DECREASED 75 0.0003
719 INTESTINAL PERFORATION 3 0.0003
720 ILL-DEFINED DISORDER 16 0.0003
721 PULMONARY EMBOLISM 25 0.0003
722 CHOLECYSTECTOMY 3 0.0003
723 INTERNAL HAEMORRHAGE 3 0.0003
724 ACIDOSIS 2 0.0003
725 BOWEL MOVEMENT IRREGULARITY 2 0.0003
726 JAUNDICE 7 0.0003
727 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
728 COGNITIVE DISORDER 12 0.0003
729 GASTROINTESTINAL DISORDER 23 0.0003
730 HYPERKALAEMIA 9 0.0003
731 DYSPHONIA 15 0.0003
732 DISORIENTATION 10 0.0003
733 PNEUMOTHORAX 4 0.0003
734 DRUG INTERACTION 40 0.0003
735 ULCER 4 0.0003
736 MACULAR DEGENERATION 3 0.0003
737 BLOOD PRESSURE FLUCTUATION 6 0.0002
738 RENAL IMPAIRMENT 21 0.0002
739 PREGNANCY 5 0.0002
740 LOCALISED INFECTION 6 0.0002
741 PALPITATIONS 29 0.0002
742 NAUSEA 195 0.0002
743 HERPES ZOSTER 14 0.0002
744 HEART RATE INCREASED 24 0.0002
745 PHOTOSENSITIVITY REACTION 4 0.0002
746 EPISTAXIS 18 0.0002
747 HYPOAESTHESIA 36 0.0002
748 OEDEMA 13 0.0002
749 CARDIO-RESPIRATORY ARREST 10 0.0002
750 CANDIDA INFECTION 4 0.0002
751 HAEMATEMESIS 6 0.0002
752 FLUID RETENTION 12 0.0002
753 CIRCULATORY COLLAPSE 4 0.0002
754 RESPIRATORY DISORDER 7 0.0002
755 DYSPEPSIA 23 0.0002
756 CARDIAC OPERATION 2 0.0002
757 BLOOD MAGNESIUM DECREASED 2 0.0002
758 NODULE 3 0.0002
759 BLOOD CREATININE INCREASED 15 0.0002
760 ORTHOSTATIC HYPOTENSION 4 0.0002
761 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
762 PULMONARY CONGESTION 3 0.0002
763 GALLBLADDER DISORDER 4 0.0002
764 DIABETES MELLITUS 17 0.0002
765 PAIN OF SKIN 6 0.0002
766 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
767 ABDOMINAL DISTENSION 23 0.0002
768 LEUKOPENIA 11 0.0002
769 ACUTE HEPATIC FAILURE 3 0.0002
770 CATARACT 13 0.0002
771 BRAIN NEOPLASM 2 0.0002
772 DYSPNOEA 123 0.0002
773 ANAPHYLACTIC REACTION 12 0.0002
774 HAEMOPTYSIS 6 0.0002
775 COORDINATION ABNORMAL 3 0.0002
776 VOMITING 101 0.0002
777 PRODUCT DOSE OMISSION 14 0.0002
778 ERYTHEMA 44 0.0002
779 BLISTER 12 0.0002
780 IMPAIRED HEALING 7 0.0002
781 HEPATIC CIRRHOSIS 4 0.0002
782 DYSARTHRIA 8 0.0002
783 BLOOD GLUCOSE INCREASED 40 0.0002
784 COLITIS 8 0.0002
785 BLOOD URINE PRESENT 4 0.0002
786 PROTEINURIA 4 0.0002
787 ECZEMA 11 0.0002
788 PARALYSIS 3 0.0002
789 PRODUCTIVE COUGH 10 0.0002
790 DIARRHOEA 133 0.0002
791 EAR PAIN 4 0.0002
792 PRESYNCOPE 5 0.0002
793 ALOPECIA 40 0.0002
794 SINUS DISORDER 4 0.0002
795 PERIPHERAL SWELLING 31 0.0002
796 PNEUMONIA ASPIRATION 5 0.0002
797 SWELLING FACE 13 0.0002
798 CONFUSIONAL STATE 32 0.0002
799 ABDOMINAL PAIN LOWER 5 0.0002
800 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
801 MOBILITY DECREASED 14 0.0002
802 THYROID DISORDER 3 0.0002
803 HYPERHIDROSIS 25 0.0002
804 HYPERSENSITIVITY 36 0.0002
805 PERITONITIS 4 0.0002
806 HAEMATOMA 5 0.0002
807 POLLAKIURIA 8 0.0002
808 MALAISE 84 0.0002
809 COMA 9 0.0002
810 ABSCESS 3 0.0002
811 EATING DISORDER 4 0.0002
812 BREAST PAIN 2 0.0002
813 INTESTINAL OBSTRUCTION 7 0.0002
814 VISUAL IMPAIRMENT 23 0.0002
815 PAIN 114 0.0002
816 FAECES DISCOLOURED 4 0.0002
817 HYPOTENSION 37 0.0002
818 VAGINAL HAEMORRHAGE 8 0.0002
819 PALLOR 5 0.0002
820 SEIZURE 21 0.0002
821 COUGH 50 0.0002
822 CHROMATURIA 4 0.0002
823 CONTUSION 17 0.0002
824 INSOMNIA 47 0.0002
825 PRODUCT AVAILABILITY ISSUE 4 0.0002
826 BRONCHITIS 13 0.0002
827 MULTI-ORGAN FAILURE 3 0.0002
828 MUSCLE TWITCHING 4 0.0002
829 ABDOMINAL DISCOMFORT 29 0.0002
830 BLOOD CHOLESTEROL INCREASED 8 0.0002
831 DEVICE USE ISSUE 3 0.0002
832 ACNE 13 0.0002
833 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
834 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
835 PSYCHOTIC DISORDER 5 0.0002
836 MIGRAINE 16 0.0002
837 MEMORY IMPAIRMENT 23 0.0002
838 BLOOD POTASSIUM DECREASED 5 0.0002
839 GASTROENTERITIS VIRAL 3 0.0002
840 NEURALGIA 4 0.0002
841 END STAGE RENAL DISEASE 3 0.0002
842 RESTLESSNESS 6 0.0002
843 DEPRESSION 37 0.0002
844 EYE SWELLING 6 0.0002
845 HYPOCALCAEMIA 3 0.0002
846 FRACTURE 3 0.0002
847 GASTRIC ULCER 3 0.0002
848 SLEEP APNOEA SYNDROME 3 0.0002
849 INCREASED APPETITE 3 0.0002
850 METABOLIC ACIDOSIS 5 0.0002
851 SKIN FISSURES 3 0.0002
852 DEAFNESS 4 0.0002
853 SKIN IRRITATION 7 0.0002
854 PARAESTHESIA 24 0.0002
855 BEDRIDDEN 2 0.0002
856 ADVERSE EVENT 14 0.0002
857 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
858 ADVERSE REACTION 2 0.0002
859 COVID-19 26 0.0001
860 DRUG INEFFECTIVE 195 0.0001
861 TASTE DISORDER 3 0.0001
862 URINARY TRACT INFECTION 25 0.0001
863 GASTRIC DISORDER 5 0.0001
864 RHABDOMYOLYSIS 6 0.0001
865 FEELING COLD 4 0.0001
866 INFLUENZA 16 0.0001
867 APHONIA 2 0.0001
868 BURNING SENSATION 10 0.0001
869 SLEEP DISORDER 10 0.0001
870 JOINT SWELLING 17 0.0001
871 PRURITUS GENERALISED 3 0.0001
872 PRODUCT PRESCRIBING ISSUE 3 0.0001
873 RENAL INJURY 4 0.0001
874 ORAL PAIN 3 0.0001
875 THROAT IRRITATION 6 0.0001
876 ADVERSE DRUG REACTION 12 0.0001
877 NEPHROLITHIASIS 6 0.0001
878 TINNITUS 6 0.0001
879 DIZZINESS 65 0.0001
880 WEIGHT INCREASED 29 0.0001
881 ANKLE FRACTURE 2 0.0001
882 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
883 BASAL CELL CARCINOMA 2 0.0001
884 BRAIN FOG 2 0.0001
885 DRUG-INDUCED LIVER INJURY 4 0.0001
886 ARTHRITIS 10 0.0001
887 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
888 MEDICATION ERROR 7 0.0001
889 CYSTITIS 4 0.0001
890 TOXICITY TO VARIOUS AGENTS 21 0.0001
891 HYPOGLYCAEMIA 6 0.0001
892 FALL 41 0.0001
893 EYE IRRITATION 7 0.0001
894 GASTROINTESTINAL HAEMORRHAGE 10 0.0001
895 UNEVALUABLE EVENT 9 0.0001
896 RENAL FAILURE ACUTE 5 0.0001
897 HYPOPHAGIA 3 0.0001
898 PRODUCT USE ISSUE 22 0.0001
899 RECTAL HAEMORRHAGE 5 0.0001
900 ANAPHYLACTIC SHOCK 3 0.0001
901 DIPLOPIA 3 0.0001
902 SOMNOLENCE 23 0.0001
903 EAR INFECTION 3 0.0001
904 ANXIETY 32 0.0001
905 PRODUCT DOSE OMISSION ISSUE 33 0.0001
906 CONDITION AGGRAVATED 34 0.0001
907 LIMB INJURY 3 0.0001
908 DRUG EFFECT INCOMPLETE 4 0.0001
909 SYNCOPE 11 0.0001
910 BONE DISORDER 2 0.0001
911 RESPIRATORY ARREST 3 0.0001
912 BLOOD GLUCOSE ABNORMAL 2 0.0001
913 PROCEDURAL PAIN 3 0.0001
914 OROPHARYNGEAL PAIN 10 0.0001
915 AMNESIA 7 0.0001
916 OXYGEN SATURATION DECREASED 6 0.0001
917 PRURITUS 41 0.0001
918 ASTHMA 12 0.0001
919 HALLUCINATION 8 0.0001
920 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
921 OCULAR HYPERAEMIA 5 0.0001
922 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
923 SURGERY 6 0.0001
924 WHEEZING 6 0.0001
925 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
926 ABORTION SPONTANEOUS 4 0.0001
927 GAIT DISTURBANCE 19 0.0001
928 VERTIGO 6 0.0001
929 FLUSHING 10 0.0001
930 SKIN BURNING SENSATION 7 0.0001
931 SINUSITIS 10 0.0001
932 LIMB DISCOMFORT 3 0.0001
933 PRODUCT USE IN UNAPPROVED INDICATION 24 0.0001
934 TREMOR 16 0.0001
935 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
936 URTICARIA 16 0.0001
937 HEAD INJURY 3 0.0001
938 MOOD SWINGS 3 0.0001
939 HIP FRACTURE 3 0.0001
940 LACTIC ACIDOSIS 3 0.0001
941 BALANCE DISORDER 8 0.0001
942 INTENTIONAL PRODUCT MISUSE 8 0.0001
943 OSTEONECROSIS 3 0.0001
944 HAEMATOCHEZIA 5 0.0001
945 FLATULENCE 5 0.0001
946 NASOPHARYNGITIS 16 0.0001
947 HAEMORRHAGE 9 0.0001
948 LOSS OF CONSCIOUSNESS 11 0.0001
949 PANIC ATTACK 3 0.0001
950 DISCOMFORT 5 0.0001
951 DYSGEUSIA 6 0.0001
952 HOT FLUSH 6 0.0001
953 CHRONIC KIDNEY DISEASE 6 0.0001
954 THERAPY CESSATION 4 0.0001
955 DISTURBANCE IN ATTENTION 4 0.0001
956 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 15 0.0001
957 FOETAL EXPOSURE DURING PREGNANCY 6 0.0001
958 BLINDNESS 3 0.0001
959 ARTHROPATHY 4 0.0001
960 ROAD TRAFFIC ACCIDENT 3 0.0001
961 MENTAL DISORDER 3 0.0001
962 MUSCULOSKELETAL STIFFNESS 6 0.0001
963 ILLNESS 7 0.0001
964 IRRITABILITY 4 0.0001
965 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
966 FEELING HOT 4 0.0001
967 DISEASE RECURRENCE 3 0.0001
968 PROSTATE CANCER 5 0.0001
969 INFLUENZA LIKE ILLNESS 5 0.0001
970 ANGER 2 0.0001
971 NERVOUSNESS 3 0.0001
972 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
973 THERAPY INTERRUPTED 4 0.0001
974 AGITATION 4 0.0001
975 DRUG DOSE OMISSION 9 0.0001
976 CONVULSION 3 0.0001
977 ABNORMAL BEHAVIOUR 2 0.0001
978 INJECTION SITE HAEMORRHAGE 4 0.0001
979 FEELING ABNORMAL 12 0.0001
980 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 9 0.0000
981 SUICIDE ATTEMPT 3 0.0000
982 NEOPLASM MALIGNANT 3 0.0000
983 INCORRECT DOSE ADMINISTERED 10 0.0000
984 SWELLING 4 0.0000
985 INJURY 3 0.0000
986 BLOOD GLUCOSE DECREASED 2 0.0000
987 AGGRESSION 2 0.0000
988 PRODUCT STORAGE ERROR 3 0.0000
989 BLADDER CANCER 2 0.0000
990 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
991 SUICIDAL IDEATION 3 0.0000
992 INJECTION SITE ERYTHEMA 3 0.0000
993 OVERDOSE 5 0.0000